JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB278073

LDN 193189 dihydrochloride

Be the first to review this product! Submit a review

|

(3 Publications)

MW 479.4 Da, Purity >99%. Potent and selective inhibitor of ALK2 (IC50 = 5 nM) and ALK3 (IC50 = 30 nM), thereby inhibiting SMAD1/5/8 phosphorylation.

Key facts

CAS number

1435934-00-1

Purity

>99%

Form

Solid

form

Molecular weight

479.4 Da

Molecular formula

C<sub>2</sub><sub>5</sub>H<sub>2</sub><sub>4</sub>Cl<sub>2</sub>N<sub>6</sub>

PubChem

91900717

Nature

Synthetic

Solubility

Soluble in water to 10 mM

Biochemical name

LDN 193189 dihydrochloride

Biological description

Potent and selective inhibitor of ALK2 (IC50 = 5 nM) and ALK3 (IC50 = 30 nM), thereby inhibiting SMAD1/5/8 phosphorylation.

Canonical smiles

C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3.Cl.Cl

InChi

InChI=1S/C25H22N6.2ClH/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30;;/h1-10,15-17,26H,11-14H2;2*1H

InChiKey

CMQXLLAILGGLRV-UHFFFAOYSA-N

IUPAC Name

4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;dihydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

American journal of stem cells 2:119-31 PubMed23862100

2013

A robust method to derive functional neural crest cells from human pluripotent stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Faith R Kreitzer,Nathan Salomonis,Alice Sheehan,Miller Huang,Jason S Park,Matthew J Spindler,Paweena Lizarraga,William A Weiss,Po-Lin So,Bruce R Conklin

Nature biotechnology 30:715-20 PubMed22750882

2012

Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.

Applications

Unspecified application

Species

Unspecified reactive species

Stuart M Chambers,Yuchen Qi,Yvonne Mica,Gabsang Lee,Xin-Jun Zhang,Lei Niu,James Bilsland,Lishuang Cao,Edward Stevens,Paul Whiting,Song-Hai Shi,Lorenz Studer

Nature medicine 14:1363-9 PubMed19029982

2008

BMP type I receptor inhibition reduces heterotopic [corrected] ossification.

Applications

Unspecified application

Species

Unspecified reactive species

Paul B Yu,Donna Y Deng,Carol S Lai,Charles C Hong,Gregory D Cuny,Mary L Bouxsein,Deborah W Hong,Patrick M McManus,Takenobu Katagiri,Chetana Sachidanandan,Nobuhiro Kamiya,Tomokazu Fukuda,Yuji Mishina,Randall T Peterson,Kenneth D Bloch
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com